The scientist’s investigation covers issues in NMDA receptor, Receptor, Glutamate receptor, Agonist and Biochemistry. His work in the fields of NMDA receptor, such as GRIN2A, intersects with other areas such as Channel blocker. A large part of his Receptor studies is devoted to Kainate receptor.
His study explores the link between Agonist and topics such as Glutamate binding that cross with problems in Binding domain. His work in Ion channel linked receptors tackles topics such as Metabotropic glutamate receptor 5 which are related to areas like Cell biology. The study incorporates disciplines such as Metabotropic glutamate receptor 1, Neuroscience and Metabotropic glutamate receptor 2 in addition to Cell biology.
His primary areas of investigation include NMDA receptor, Receptor, Glutamate receptor, Agonist and Neuroscience. His work carried out in the field of NMDA receptor brings together such families of science as Biophysics, Stereochemistry, Allosteric regulation and Ion channel. His Receptor research includes themes of Mutation, Neuroprotection and Cell biology.
His Glutamate receptor research is multidisciplinary, relying on both Endocrinology, Hippocampus and Ligand-gated ion channel. His Agonist study incorporates themes from Binding domain, Neurotransmission and Transmembrane domain. His Neuroscience research is multidisciplinary, incorporating perspectives in Ion channel linked receptors, Antagonist and Postsynaptic potential.
His main research concerns NMDA receptor, Receptor, Glutamate receptor, Agonist and Allosteric regulation. Hongjie Yuan usually deals with NMDA receptor and limits it to topics linked to Biophysics and Allosteric modulator. As a member of one scientific family, Hongjie Yuan mostly works in the field of Receptor, focusing on Protein subunit and, on occasion, Central nervous system and Molecular biology.
His study brings together the fields of Neuroscience and Glutamate receptor. His Epilepsy study, which is part of a larger body of work in Neuroscience, is frequently linked to Pregnenolone sulfate, bridging the gap between disciplines. His study in Agonist is interdisciplinary in nature, drawing from both Neurotransmission and Cell biology.
Hongjie Yuan mostly deals with Receptor, GRIN2A, GRIN2B, Cell biology and Glutamate receptor. His Receptor research is mostly focused on the topic NMDA receptor. The various areas that he examines in his NMDA receptor study include Neuroprotection, Potentiator, Pharmacology, Structural biology and Allosteric regulation.
Hongjie Yuan combines subjects such as Disease, Intellectual disability and Neuroscience with his study of GRIN2A. He has researched GRIN2B in several fields, including Missense mutation, GRIN1, Excitatory postsynaptic potential and Epilepsy. His Cell biology research is multidisciplinary, incorporating elements of Ionotropic effect, Agonist, Protein subunit, Neurotransmission and Transmembrane domain.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Emory University
Emory University
Emory University
University of California, San Diego
University of Minnesota
Emory University
National Institutes of Health
Université Paris Cité
AstraZeneca (United Kingdom)
University of British Columbia